A Deep Learning Multi-Class Model for Drug-Target Binding Affinity Prediction

Authors

  • Nassima Aleb Computer Science Department, Jubail University College, Jubail Industrial City, Kingdom of Saudi Arabia

Keywords:

Deep learning models for drug discovery, Drug repurposing, Drug-target binding affinity, Discretization, Multi-class classification models

Abstract

Drug design and discovery is a very challenging and costly process. It involves a crucial phase of drug-target interaction (DTIs) identification. Nevertheless, most existing methods use either binary classification to predict the presence of an interaction in a Drug-Target pair, or regression methods to predict the exact float-value representing the Binding Affinity. These latter methods are more valuable but suffer from unsatisfactory results despite their very sophisticated models and multiple inputs. In this paper, we present a new approach for predicting the strength of drug-target binding, we tackle the question as a Multi-class classification problem. This approach is very rational since the key points, in drug-target interaction, are to have a precise indication about the binding strength and to establish a ranking between drug-target pairs’ binding strengths.  Our model input being sequences presenting hidden patterns, we use convolutional LSTM networks, since they inherit the ability in discovering patterns from Convolutional networks, and learning from sequential data from recurrent networks. Besides the usual performance metrics, we investigate new interesting performance metrics that have never been explored before.  The results show that our approach is very convincing.

References

Thafar M, Raies AB, Albaradei S, Essack M and Bajic VB (2019) Comparison Study of Computational Prediction Tools for Drug-Target Binding Affinities. Front. Chem. 7:782. doi: 10.3389/fchem.2019.00782

Hu, P. Chan, KCC. You, Z. Large-scale prediction of drug– target interactions from deep representations. International Joint Conference on Neural Networks (IJCNN), Vancouver, BC, Canada. IEEE, 2016,pp. 1236–1243

Hamanaka,M. Kei Taneishi Hiroaki Iwata Jun Ye Jianguo Pei Jinlong Hou Yasushi Okuno. Cgbvs-dnn: prediction of compound– protein interactions based on deep learning. Mol. Inform., 36. doi: 10.1002/minf.201600045.

Truchon JF, Bayly CI. Evaluating virtual screening methods: good and bad metrics for the "early recognition" problem. J. Chem. Inf. Model 47(2), 2007, pp.488–508

Carpenter, K. A., Cohen, D. S., Jarrell, J. T., & Huang, X. Deep learning and virtual drug screening. Future medicinal chemistry, 10(21), 2018, pp.2557–2567. https://doi.org/10.4155/fmc-2018-0314

Feng, Q. (2019). PADME: A Deep Learning-based Framework for Drug-Target Interaction Prediction (Master thesis), Simon Fraser University, Burnaby, BC, Canada.

Ballester,P.J. and Mitchell,J.B. A machine learning approach t predicting protein–ligand binding affinity with applications to molecular docking. Bioinformatics, 26, 1169–1175. 2010.

F Li,H. et al. Low-quality structural and interaction data improves binding affinity prediction via random forest. Molecules, 20, 10947–10962. ; 2015.

Shar,P.A. et al. Pred-binding: large-scale protein–ligand binding affinity prediction. J. Enzyme Inhib. Med. Chem., 31, 1443–1450. 2016.

Gabel,J. et al. Beware of machine learning-based scoring functions on the danger of developing black boxes. J. Chem. Inf. Model., 54, 2807–2815. 2014.

He,T. et al. Simboost: a read-across approach for predicting drug–target binding affinities using gradient boosting machines. J. Cheminform., 9, 24. 2017.

Pahikkala, T., Airola, A., Pietilä, S., Shakyawar, S., Szwajda, A., Tang, J., et al Toward more realistic drug-target interaction predictions. Brief. Bioinformatics 2015.

Schmidhuber J. Deep learning in neural networks: An overview. Neural networks, 61:85{117, 2015.

Ciregan,D. et al. Multi-column deep neural networks for image classification. In: 2012 IEEE Conference on Computer Vision and Pattern Recognition (CVPR), Providence, Rhode Island. IEEE, pp. 3642–3649. and computer vision (Ciregan et al., 2012.

Donahue,J. et al. Decaf: a deep convolutional activation feature for generic visual recognition. In: ICML, Beijing, China, 2014, pp. 647–655.

Simonyan,K. and Zisserman,A. Very deep convolutional networks for large-scale image recognition. In: 3rd International Conference on Learning Representations (ICLR), Hilton San Diego Resort & Spa, May 7–9, 2015.

Dahl,G.E. et al. Context-dependent pre-trained deep neural networks for large-vocabulary speech recognition. IEEE Trans. Audio Speech Lang. Process., 20, 30–42.Speech recognition, natural language processing (Dahl et al., 2012.

Graves,A. et al. Speech recognition with deep recurrent neural networks. In: 2013 IEEE international conference on acoustics, speech and signal processing, Vancouver, Canada. IEEE, 2013, pp. 6645–6649.

Hinton,G. et al. Deep neural networks for acoustic modeling in speech recognition: the shared views of four research groups. IEEE 2012, Signal Process. Mag., 29, 82–97.

Leung,M.K. et al. Deep learning of the tissue-regulated splicing code. Bioinformatics, 30, 2014, i121–i129.

Xiong,H.Y. et al. The human splicing code reveals new insights into the genetic determinants of disease. Science, 347, 2015, 1254806.

Ma,J. et al. Deep neural nets as a method for quantitative structure–activity relationships. J. Chem. Inf. Model., 55, 2015, pp.263–274.

Jing, Y., Bian, Y., Hu, Z.,Wang, L., and Xie, X.-Q. S. (2018). Deep learning for drug design: an artificial intelligence paradigm for drug discovery in the big data era. AAPS J. 2018, 20:58. doi: 10.1208/s12248-018-0210-0.

Ekins, S., Puhl, A. C., Zorn, K.M., Lane, T. R., Russo, D. P., Klein, J. Exploiting machine learning for end-to-end drug discovery and development Nat. Mater. 18, 2019, pp.435–441. doi: 10.1038/s41563-019-0338.

LeCun, Y. Bengio, and G. Hinton. Deep learning. nature, 521(7553):436-444 (2015).

Weininger, D. SMILES, a chemical language and information system. 1. Introduction to methodology and encoding rules. J. Chem. Inf. Model. 28, 1988, pp.31–36. doi: 10.1021/ci00057a005.

Krig, S. Feature learning and deep learning architecture survey, in Computer Vision Metrics (Cham: Springer), 2016, pp.375–514. doi: 10.1007/978-3-319-33762-3.

Gomez-Bombarelli,R. et al.Automatic chemical design using a data-driven continuous representation of molecules. ACS Cent. Sci., 4, 2018,pp.268–276.

Jastrzkeski,S. et al. Learning to smile (s). arXiv preprint arXiv: 1602.06289. (2016).

Gomes,J. et al. (2017) Atomic convolutional networks for predicting protein–ligand binding affinity. arXiv preprint arXiv: 1703.10603.

Ragoza,M. et al. Protein–ligand scoring with convolutional neural networks. J. Chem. Inf. Model., 57, 2017, pp.942–957.

Wallach,I. et al. Atomnet: a deep convolutional neural network for bioactivity prediction in structure-based drug discovery. arXiv preprint arXiv: 2015, 1510.02855. [35]

Öztürk, H., Özgür, A., and Ozkirimli, E. DeepDTA: deep drug-target binding affinity prediction. Bioinformatics 34 2018, i821–i829. doi: 10.1093/bioinformatics

Öztürk, H., Ozkirimli, E., and Özgür, A. (2019). WideDTA: prediction of drugtarget binding affinity. 2019, arXiv:1902.04166. Available online at: https://arxiv.org.

Karimi, M., Wu, D., Wang, Z., and Shen, Y. DeepAffinity: interpretable deep learning of compound-protein affinity through unified recurrent and convolutional neural networks. Bioinformatics 35, 2019, pp.3329–3338. doi: 10.1093/bioinformatics/btz111.

Rogers, D., and Hahn, M. Extended-connectivity fingerprints. J. Chem. Inf. Model. 50, 2010, pp.742–754. doi: 10.1021/ci100050.

Liu, K., Sun, X., Jia, L.,Ma, J., Xing, H.,Wu, J., et al. Chemi-Net: a molecular graph convolutional network for accurate drug property prediction. Int. J.Mol Sci.2019, 20:3389. doi: 10.3390/ijms20143389.

Gromiha, M. Protein Bioinformatics: From Sequence to Function. New Delhi: Academic Press. 2011.

Yamanishi,Y. et al. Prediction of drug–target interaction networks from the integration of chemical and genomic spaces. Bioinformatics, 2008, 24, i232–i240.

Davis,M.I. et al. Comprehensive analysis of kinase inhibitor selectivity. Nat. Biotechnol., 29, 1046–1051.

Metz, J. T., Johnson, E. F., Soni, N. B., Merta, P. J., Kifle, L., and Hajduk, P. J. Navigating the kinome. Nat. Chem. Biol. 7, 2011, 200–202doi: 10.1038/nchembio.530.

Tang,J. et al. Making sense of large-scale kinase inhibitor bioactivity data sets: a comparative and integrative analysis. J. Chem. Inf. Model., 54, 2014, pp.735–743.

Weiss, S.,.Rule-base Regression. In Proceedings of the 13th International Joint Conference on Artificial Intelligence 1993,, pp. 1072-1078.

Indurkhya, N.Rule-based Machine Learning Methods for Functional Prediction. In Journal Of Artificial Intelligence Research (JAIR), volume 3, 1995, pp.383-403.

Chollet,F. et al. (2015) Keras. https://github.com/fchollet/keras.

Kang,L. et al. Convolutional neural networks for no-reference image quality assessment. In: Proceedings of the IEEE Conference on Computer Vision and Pattern Recognition, Washington, DC, USA, 2014, pp. 1733–1740.

Goodfellow I., Bengio Y., Courville A. Deep Learning. MIT Press, http://www.deeplearningbook.org 2016.

Gonen,M. and Heller,G. Concordance probability and discriminatory power in proportional hazards regression. Biometrika, 2005, 92, 965–970.

Weston, J., Chris W., Support Vector Machines for Multi-Class Pattern Recognition. European Symposium on Artificial Neural Networks 1999.

d Abadi,M. et al. (2016) Tensorflow: a system for large- learning. In: OSDI scale machine, Vol. 16, pp. 265–283.

Downloads

Published

2022-05-23

How to Cite

Nassima Aleb. (2022). A Deep Learning Multi-Class Model for Drug-Target Binding Affinity Prediction. International Journal of Applied Sciences: Current and Future Research Trends, 13(1), 236–252. Retrieved from https://ijascfrtjournal.isrra.org/index.php/Applied_Sciences_Journal/article/view/1184

Issue

Section

Articles